| 000 | 01093 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515211038.0 | ||
| 264 | 0 | _c20100617 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1165-158X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMori, T A | |
| 245 | 0 | 0 |
_aOmega-3 fatty acids and blood pressure. _h[electronic resource] |
| 260 |
_bCellular and molecular biology (Noisy-le-Grand, France) _cFeb 2010 |
||
| 300 |
_a83-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCatecholamines _xphysiology |
| 650 | 0 | 4 | _aControlled Clinical Trials as Topic |
| 650 | 0 | 4 |
_aEndothelium _xdrug effects |
| 650 | 0 | 4 |
_aFatty Acids, Omega-3 _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMeta-Analysis as Topic |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 773 | 0 |
_tCellular and molecular biology (Noisy-le-Grand, France) _gvol. 56 _gno. 1 _gp. 83-92 |
|
| 999 |
_c19564782 _d19564782 |
||